ARA KAYAYAN: Open Payments
NPI 1205828316 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,239 in 113 payments from 26 companies in 2025. Trend: 2023 $1,652 · 2024 $1,773 · 2025 $2,239
Food & beverage: $2,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $344 |
| Novo Nordisk Inc | 13 | $288 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $139 |
| GlaxoSmithKline, LLC. | 8 | $135 |
| Amgen Inc. | 8 | $128 |
| PFIZER INC. | 6 | $122 |
| Exact Sciences Corporation | 4 | $103 |
| Lilly USA, LLC | 5 | $103 |
| Axsome Therapeutics, Inc. | 4 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
Products named: QULIPTA, Wegovy, The Cologuard Plus Collection Kit, VRAYLAR, UBRELVY, Auvelity, GEMTESA, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
